AU6467999A - Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi - Google Patents
Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi Download PDFInfo
- Publication number
- AU6467999A AU6467999A AU64679/99A AU6467999A AU6467999A AU 6467999 A AU6467999 A AU 6467999A AU 64679/99 A AU64679/99 A AU 64679/99A AU 6467999 A AU6467999 A AU 6467999A AU 6467999 A AU6467999 A AU 6467999A
- Authority
- AU
- Australia
- Prior art keywords
- afp
- plant
- plant pathogenic
- pathogenic fungi
- antifungal protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/14—Plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
The invention relates to the use of an antifungal protein (AFP) having a molecular weight of approximately 10kDa from Streptomyces tendae against plant pathogenic fungi from the Ascomycetes family.
Description
WO 00/22932 PCT/EP99/07364 Description Utilization of an antifungal protein from Streptomyces tendae against plant pathogenic fungi 5 The present invention relates to the use of an antifungal protein (AFP) having a molecular weight of approx. 10 kDa from Streptomyces tendae against plant pathogenic fungi from the Ascomycetes family. 10 Antifungal proteins have been described for some time, some of these proteins also being termed PR proteins (plant pathogenesis-related proteins) in the case of plants (Bol, J.F. & Linthorst, H.J.M. (1990), Annu. 15 Rev. Phytopathol., 28, 113). These proteins are formed by plants under stress conditions, for example in the case of viral or fungal infection, inducing an active defense mechanism of the plant which is termed "induced resistance" (Lindhorst, H.J.M., (1991) Cri. Rev. Plant 20 Sci., 10(2), 123). Some of these proteins have, for example, a chitinase activity or P-1,3-glucanase activity. Proteins with an antifungal activity have already been 25 detected from microorganisms too, some of these proteins also showing chitinase activity or 1-1,3 glucanase activity. Other proteins, in contrast, act via an interaction of the fungal cell wall. 30 For example, an antifungal protein (AFP) having a size of approx. 10 kDa which is active against the fungal species Paecilomyces varriotii, Byssoclamis nivea, Pencillium puberulum and Eupenicillium terrum has been isolated from Streptomyces tendae. However, the action 35 was restricted to these species. Other species such as, for example, Paecilomyces carneus, Paecilomyces lilacenus, Penicillium chrysogenum or Penicillium claviforme are not inhibited. In addition, the use of WO 00/22932 - 2 - PCT/EP99/07364 AFP is not justified commercially either since the fungal species mentioned are not plant pathogenic. The object of the present invention was therefore to 5 find an antifungal protein which is active against plant pathogenic fungi. Surprisingly, it has now been found that AFP from Streptomyces tendae is active against plant pathogenic 10 fungi from the Ascomycetes family. The subject-matter of present the invention is therefore the use of an antifungal protein (AFP) with a molecular weight of approx. 10 kDa from Streptomyces 15 tendae against plant pathogenic fungi from the Ascomycetes family, in particular against Botrytis cinera. The antifungal protein mentioned contains a typical 20 amino-terminal signal sequence, i.e. a hydrophilic N-terminus is followed by a hydrophobic transmembrane region, which cause extracellular secretion. Moreover, two forms are known, namely a shorter form with a molecular weight of approx. 9 860 Da and a longer form 25 with a molecular weight of approx. 10 300 Da. Since AFP is secreted by Streptomyces tendae into the culture medium, it can be isolated for example directly from the Streptomyces tendae culture filtrate, 30 following methods known to the skilled worker. As an alternative, AFP can be produced by genetic engineering, the gene isolated preferably being cloned into a so-called multicopy vector, for example plJ702 (Hopwood, D.A. et al. (1985) Genetic Manipulation of 35 Streptomyces. A Laboratory Manual. Norwich, U.K.) and using this construction to transform a suitable strain, for example the non-nikkomycin-producing strain Streptomyces tendae NP9. An example of an AFP-encoding WO 00/22932 - 3 - PCT/EP99/07364 nucleic acid is shown in SEQ ID No. 1. When this preferred transformant was grown, for example, for 7 days in 200 ml of nutrient solution, approx. 6 mg of AFP were obtained, which corresponds to 30 mg of AFP/l. 5 The production of AFP by genetic engineering via a preferably controlled fermentation, is therefore especially preferred. For the use in accordance with the invention, AFP can 10 be applied directly for example in the form of a formulation together with preferably at least one additional auxiliary. To this end, for example, plants attacked by fungi or endangered by fungal attack are sprayed with the formulation described. The AFP 15 concentration of the formula is generally from approx. 10 pg/ml up to approx. 500 mg/ml. Suitable auxiliaries are, for example, protease inhibitors, stabilizers such as glycerol, sucrose, salts, solvents or generally known substances from the field of crop protection. 20 So-called transgenic plants which are capable of producing AFP themselves are another possibility of providing protection against fungal infection. 25 Another embodiment is therefore the use according to the invention of AFP, the AFP being formed in a transgenic plant. The transgenic plant is, preferably, genetically engineered maize, cotton, potato, banana, Arabidopsis, casava, tobacco, oilseed rape (canola), 30 potato, sugar beet, cereals such as, for example, wheat, barley or oats, strawberries, vegetables such as, for example, cabbage, legumes such as, for example, peas or beans, tomato, lettuce or melon. 35 To generate a transgenic plant, a nucleic acid encoding AFP, for example in the form of naked DNA, viral DNA or RNA, or in the form of plasmid DNA, is introduced into a plant cell. An example of an AFP-encoding nucleic WO 00/22932 - 4 - PCT/EP99/07364 acid is shown in SEQ ID No. 1. However, the present invention -also covers those nucleic acids which differ from the nucleic acid sequence of SEQ ID No. 1 owing to the degeneracy of the genetic code, but which encodes 5 the same AFP amino acid sequence. Moreover, the invention covers those mutants or variants of the nucleic acid of SEQ ID No. 1 which encode an AFP protein which is active against plant pathogenic fungi of the Ascomycetes family, in particular against 10 Botrytis cinera. These include, for example, fusion proteins of the AFP protein with other foreign proteins or an AFP protein with an N-terminally deleted methionine. Other examples of variants are nucleic acids which hybridize on the stringent conditions with 15 the nucleic acid of SEQ ID No. 1. The stringent hybridization conditions can be determined for example by Sambrook, J. et al. in Molecular Cloning, A Laboratory Manual, 2nd Edition, Cold Spring Habour Laboratory Press, 1989. Transgenic plants are 20 subsequently regenerated from the transformed plant cells. Preferably, an AFP-encoding nucleic acid can be introduced into the plant cell by means of recombinant agrobacteria, by electroporation, by bombardment with microparticles and/or by means of polyethylene glycol. 25 The infection with recombinant Agrobacterium tumefaciens bacteria in plant cells of dicots is described, for example, by Klee, H. et al. (1997) Annu. Rev. Plant Physiol. 38, 467 or EP-B2-0122791). The 30 infection with recombinant Agrobacterium tumefaciens bacteria in plant cells of monocots is described, for example, by Ishida, Y. et al. (1996) Nature Biotech. 14, 745 with reference to maize (Zea mays L.). The agrobacteria used for this purpose have a T-DNA into 35 which the AFP-expressing gene and, if appropriate, a suitable promoter, for example a plant phaseolin promoter (see, for example, EP-B2-0122791) or a viral 35S promoter (see, for example, Ishida, Y. et al.
WO 00/22932 - 5 - PCT/EP99/07364 (1996), above) had been inserted. The T-DNA can be transferred into plant, cells for example by coculturing the recombinant agrobacteria together with immature embryos of the plant in question (see, for example, 5 Ishida, Y. et al. (1996), above). To select the transformed plant cells, it is preferred to use T-DNA constructs which are capable of expressing, in the plant cell, a resistance gene from the AFP gene to be expressed. A suitable resistance gene is, for example, 10 the gene encoding phosphinothricin acetyltransferase (see, for example, Ishida, Y. et al. (1996), above). Thus, successfully transformed plant cells can be selected for example by means of the corresponding antibiotic phosphinothricin. The regeneration of a 15 plant from transformed plant cells is generally known (see, for example, Sagi et al. (1995), Nature Biotech, 13, 481-485, Ishida, Y. et al. (1996), above, or Sch6pke et al. (1996), Nature Biotech, 14, 731-735. 20 In addition to the use of Agrobacterium tumefaciens as transformation means, other transformation methods are known and suitable, such as, for example, electro poration, the bombardment with microparticles or the use of polyethylene glycol (see, for example, Potrykos, 25 (1991) Annu. Rev. Plant Physiol. Mol. Biol., 42, 205; Estruch, J.J. et al. (1997), Nature Biotech., 15, 137 141 or Dingermann, T. (1995) BIOforum, 18, 252). For example, casava (Sch6pke et al. (1996), above) or banana (Sagi, et al. (1995), above) have already been 30 transformed by bombarding plant cells with DNA-coated particles. In this method too, the AFP gene to be expressed is cloned into a suitable vector which preferably has a resistance gene allowing the subsequent selection of the transformed plant cells. 35 The recombinant vector is preferably applied to tungsten particles with which, for example, suspensions of embryogenic cells are bombarded (see, for example, Sagi, et al. (1995), above). The cell suspensions WO 00/22932 - 6 - PCT/EP99/07364 treated thus are subsequently selected for transformed plant cells using a suitable antibiotic, for example phosphinothricin, and a transgenic plant is regenerated therefrom, for example as already described above. 5 A considerable advantage of the present invention is that AFP is active against plant pathogenic fungi from the Ascomycetes family, in particular against Botrytis Cinera, which have already developed a resistance in 10 particular to one or more crop protection agents. The examples which follow and the figure are intended to describe the invention in greater detail without imposing any limitation: 15 Sequence description SEQ ID No. 1 shows a nucleic acid sequence encoding an antifungal (223) protein (AFP) from 20 Streptomyces tendae. Examples Example 1: 25 To prepare test plates, 50 pl of a spore suspension of Botrytis cinerae were added to 100 ml of test agar (20 g/l malt extract, 10 g/l glucose, 2 g/l yeast extract, 0.5 ammonium sulfate, 15 g/l agar, pH 6.0). 30 25 ml of this were poured into Petri dishes. The final spore concentration was 105 spores/ml. Sterile anti biotic test disks (Schleicher und Schuell, Dassel, Frg) 0.5 cm in diameter were subsequently applied to a test plate. Then, 5, 10, 15 and 20 pl of the AFP solution 35 (100 mg/ml lyophilized culture filtrate of S. tendae transformants) were subsequently pipetted onto the test disks and the test plate was incubated for 4 days at A4/ 30 0 C. The diameter of the inhibitory zone was 0.7 cm WO 00/22932 - 7 - PCT/EP99/07364 for 5 ptl of AFP solution, 1 cm diameter for 10 pl, 1.3 cm for 15 pl of solution and 1.9 cm for 20 pl. Example 2: 5 To prepare test plates, 50 pl of a spore suspension of Botrytis cinerae ZF 3629 (resistant to BCM (Benlat, BenomylTM, Hoechst Schering AgrEvo GmbH, Frankfurt, carbendazem) were added to 100 ml of test agar (20 g/l 10 malt extract, 10 g/l glucose, 2 g/l yeast extract, 0.5 ammonium sulfate, 15 g/l agar, pH 6.0) . 25 ml of this were poured into Petri dishes. The final spore concentration was 10 5 spores/ml. Sterile antibiotic test disks (Schleicher und Schuell, Dassel, Frg) 0.5 cm 15 in diameter were subsequently applied to a test plate. Then, 5, 10, 15 and 20 pl of the AFP solution (100 mg/ml lyophilized culture filtrate of S. tendae transformants) were subsequently pipetted onto the test disks and the test plate was incubated for 4 days at 20 30 0 C. The diameter of the inhibitory zone was 0.9 cm for 5 pl of AFP solution, 1.3 cm diameter for 10 pl, 1.9 cm for 15 pl of solution and 2.2 cm for 20 pl. Example 3 - Improved production by fermentation: 25 In a flask equipped with a hose, 100 ml of the preculture medium (103 g/l sucrose, 20 g Tryptic Soy Broth (Oxoid, Wesel), 10 g/l MgCl 2 and 10 g/l yeast extract) were inoculated with an agar section of strain 30 S. tendae. The culture was grown for 5 days at 28 0 C at 200 rpm on an orbital shaker. 10 1 of the production medium (103 g/l sucrose, 20 g Tryptic Soy Broth (Oxoid, Wesel), 10 g/l MgCl 2 , 10 g/l yeast extract, 100 pl desmophen, pH 7.5) were 35 inoculated with 100 ml of the above-described preculture.
WO 00/22932 - 8 - PCT/EP99/07364 The fermenter employed was a Biostat E (Braun, Melsungen) . Fermentation was carried out for 4 days at 28*C, 700 rpm and 0.5 vvm of air. Thereupon, fermentation was stopped, and the culture supernatant 5 was harvested by centrifugation at 3000 rpm and 4 0 C. The batch was subsequently dried by lyophilization. It was possible to employ the powder directly. If 15 pl of the lyophilizate (100 mg/ml) were employed against Botrytis cinerae in an inhibitory-zone test, an 10 inhibitory zone of 1.7 cm and, against Botrytis cinerae ZF 3629, an inhibitory zone of 2.3 cm were detected.
Claims (7)
1. The use of an antifungal protein (AFP) having a molecular weight of approx. 10 kDA from 5 Streptomyces tendae against plant pathogenic fungi from the Ascomycetes family, in particular against Botrytis cinera.
2. The use as claimed in claim 1, wherein AFP is used 10 in the form of a formulation together with preferably at least one auxiliary.
3. The use as claimed in claim 1, wherein AFP is formed in a transgenic plahtt. 15
4. The use as claimed in claim 3, wherein the transgenic plant is selected from among maize, cotton, potato, banana, Arabidopsis, casava, tobacco, oilseed rape (canola), potato, sugar 20 beet, cereals, strawberries, vegetables, legumes, tomato, lettuce or melon.
5. The use as claimed in claim 4, wherein cereals are selected from amongst wheat, barley or oats, the 25 vegetable used is cabbage, or the legumes are selected from amongst peas or beans.
6. The use as claimed in any of claims 3 - 5, wherein the transgenic plant comprises a nucleic acid as 30 claimed in SEQ ID No. 1, SEQ ID No. 1 being part of the claim.
7. The use as claimed in any of claims 1 - 6, wherein the plant pathogenic fungus stated is resistant to 35 one or more crop protection agents.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19848517A DE19848517A1 (en) | 1998-10-21 | 1998-10-21 | Controlling phytopathogenic fungi, useful particularly against Botrytis cinerea resistant to known fungicides, by treatment with peptide from Streptomyces tendae |
DE19848517 | 1998-10-21 | ||
PCT/EP1999/007364 WO2000022932A1 (en) | 1998-10-21 | 1999-10-05 | Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6467999A true AU6467999A (en) | 2000-05-08 |
AU748455B2 AU748455B2 (en) | 2002-06-06 |
Family
ID=7885179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64679/99A Ceased AU748455B2 (en) | 1998-10-21 | 1999-10-05 | Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1123004B1 (en) |
JP (1) | JP2002527456A (en) |
KR (1) | KR20010083915A (en) |
CN (1) | CN1324214A (en) |
AT (1) | ATE217757T1 (en) |
AU (1) | AU748455B2 (en) |
CA (1) | CA2347706A1 (en) |
DE (2) | DE19848517A1 (en) |
ID (1) | ID29012A (en) |
IL (1) | IL142597A0 (en) |
MX (1) | MXPA01004057A (en) |
NZ (1) | NZ511213A (en) |
WO (1) | WO2000022932A1 (en) |
ZA (1) | ZA200103234B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100883190B1 (en) * | 2007-08-09 | 2009-02-12 | 경상대학교산학협력단 | Antibiotics preparation containing heat-stable protein having antimicrobial activity |
CN103708960B (en) * | 2013-12-24 | 2016-06-01 | 安徽师范大学 | A kind of liquid composite microbic bacterial fertilizer and production method and purposes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2537028A1 (en) * | 1975-08-20 | 1977-03-10 | Bayer Ag | ANTIBIOTICUM, A METHOD FOR ITS MANUFACTURING AND ITS USE AS A PLANT PROTECTION PRODUCT |
US4158608A (en) * | 1975-08-20 | 1979-06-19 | Bayer Aktiengesellschaft | Fungicidally active antibiotic from Streptomyces tendae Ettlinger |
-
1998
- 1998-10-21 DE DE19848517A patent/DE19848517A1/en not_active Withdrawn
-
1999
- 1999-10-05 IL IL14259799A patent/IL142597A0/en unknown
- 1999-10-05 NZ NZ511213A patent/NZ511213A/en unknown
- 1999-10-05 WO PCT/EP1999/007364 patent/WO2000022932A1/en not_active Application Discontinuation
- 1999-10-05 DE DE59901521T patent/DE59901521D1/en not_active Expired - Fee Related
- 1999-10-05 KR KR1020017004884A patent/KR20010083915A/en not_active Application Discontinuation
- 1999-10-05 MX MXPA01004057A patent/MXPA01004057A/en not_active Application Discontinuation
- 1999-10-05 AT AT99952494T patent/ATE217757T1/en not_active IP Right Cessation
- 1999-10-05 CA CA002347706A patent/CA2347706A1/en not_active Abandoned
- 1999-10-05 CN CN99812433A patent/CN1324214A/en active Pending
- 1999-10-05 AU AU64679/99A patent/AU748455B2/en not_active Ceased
- 1999-10-05 ID IDW20010845A patent/ID29012A/en unknown
- 1999-10-05 JP JP2000576718A patent/JP2002527456A/en active Pending
- 1999-10-05 EP EP99952494A patent/EP1123004B1/en not_active Expired - Lifetime
-
2001
- 2001-04-20 ZA ZA200103234A patent/ZA200103234B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1123004A1 (en) | 2001-08-16 |
JP2002527456A (en) | 2002-08-27 |
AU748455B2 (en) | 2002-06-06 |
WO2000022932A1 (en) | 2000-04-27 |
MXPA01004057A (en) | 2003-03-10 |
DE59901521D1 (en) | 2002-06-27 |
CA2347706A1 (en) | 2000-04-27 |
EP1123004B1 (en) | 2002-05-22 |
NZ511213A (en) | 2003-03-28 |
KR20010083915A (en) | 2001-09-03 |
DE19848517A1 (en) | 2000-04-27 |
ATE217757T1 (en) | 2002-06-15 |
CN1324214A (en) | 2001-11-28 |
ZA200103234B (en) | 2002-11-07 |
ID29012A (en) | 2001-07-26 |
IL142597A0 (en) | 2002-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | Deletion of two endo-β-1, 4-xylanase genes reveals additional isozymes secreted by the rice blast fungus | |
Kanzaki et al. | Overexpression of the wasabi defensin gene confers enhanced resistance to blast fungus (Magnaporthe grisea) in transgenic rice | |
US5530187A (en) | Transgenic plants containing multiple disease resistance genes | |
Van Nierop et al. | The impact of microorganisms on barley and malt quality—a review | |
HUT74393A (en) | Method of controlling plant pathogens | |
CA2183067A1 (en) | Expression of the glucose oxidase gene in transgenic organisms | |
HU217789B (en) | Process for isolating antipathogene proteins from plants, for producing them with recombinant technics, and compositions and transgenic plants containing this proteins | |
WO2006036678A2 (en) | Transgenic strains of trichoderma and their use in biocontrol | |
US20230203432A1 (en) | Beneficial microbes for delivery of effector peptides or proteins and use thereof | |
Malnoy et al. | Activation of the pathogen-inducible Gst1 promoter of potato after elicitation by Venturia inaequalis and Erwinia amylovora in transgenic apple (Malus× domestica) | |
AU748455B2 (en) | Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi | |
KR100887461B1 (en) | Disease-resistant plants and method of constructing the same | |
Lebedev et al. | Plant-defensin genes introduction for improvement of pear phytopathogen resistance | |
US20180362993A1 (en) | Elicitor-derived peptides and use thereof | |
EP0525508A2 (en) | Anti-palnogenic protein of ustilago maydis and use thereof | |
AU692228B2 (en) | Expression of the glucose oxidase gene in transgenic organisms | |
Quarantin | Role of Fusarium graminearum cerato-platanin and hydrophobin proteins in fungal growth and plant infection | |
Jacks et al. | Transformation of plants with a chloroperoxidase gene to enhance disease resistance | |
US20150373995A1 (en) | Kp6 antifungal protein-induced fungal resistance in food crops | |
HU219505B (en) | Method for targeting plant derived intracellular proteins to the extracellular space and enhancing antipathogenic effect of such proteins | |
Kim et al. | Expression of Attacin-like Antibacterial Protein NUECIN in Pleurotus ostreatus | |
Kim et al. | Generation of an Arginine Auxotrophic Mutant of Colletotrichum acutatum as a Recipient Host for Insertional Mutagenesis | |
KR20050028129A (en) | Bovine lactoferricin expressed in plants | |
KR20050028330A (en) | Porcine lactoferricin expressed in plants | |
KR20050028128A (en) | Human lactoferricin expressed in plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |